Company news
Perseus Proteomics, Inc. (TSE:4882) news
Perseus Proteomics, Inc. news releases on 6ix. Latest, Aug 13, 2026: Non-consolidated Financial Results for the Three Months Ended June 30, 2026 (Under…
Press releases & updates
Non-consolidated Financial Results for the Three Months Ended June 30, 2026 (Under Japanese GAAP)
August 13, 2026
Notice Regarding the Results of a Clinical Study in Patients Who Participated in the Phase I Clinical Trial of PPMX-T003 for Polycythemia Vera
July 1, 2026
(Amendments) Amendments to “Non-consolidated Summary of Financial Results for the Fiscal Year Ended March 31, 2026”
June 21, 2026
Perseus Proteomics : Non-consolidated Summary of Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2023
August 12, 2022
Perseus Proteomics : Notice on Determination of Stock Option (Share acquisition rights) Details
July 11, 2022
Perseus Proteomics : Notice on Issuance of Stock Option (Share acquisition rights)
June 23, 2022
Perseus Proteomics : (Amendments) Amendments to “Non-consolidated Summary of Financial Results for the Fiscal Year Ended March 31, 2022
June 23, 2022
Perseus Proteomics : Notice on Booking of Non-operating Income, Non-operating Expenses, Extraordinary Income and Extraordinary Loss
February 14, 2022